AFP and hepatocellular carcinoma: Very few circulating markers are currently used for the diagnosis of chronic liver diseases and HCC, among which, alpha-fetoprotein (AFP) is frequently used in clinics for HCC diagnosis and for evaluating tumor recurrence [182].